Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV000247467 | SCV000320012 | likely benign | Cardiovascular phenotype | 2019-06-25 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Labcorp Genetics |
RCV000545266 | SCV000625885 | benign | Duchenne muscular dystrophy | 2025-01-27 | criteria provided, single submitter | clinical testing | |
Eurofins Ntd Llc |
RCV000593944 | SCV000707460 | likely benign | not specified | 2017-04-06 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001541619 | SCV001759638 | likely benign | not provided | 2019-08-27 | criteria provided, single submitter | clinical testing | |
Ce |
RCV001541619 | SCV004164742 | likely benign | not provided | 2022-12-01 | criteria provided, single submitter | clinical testing | DMD: BP4, BS2 |
Natera, |
RCV001833292 | SCV002089661 | likely benign | Becker muscular dystrophy; Duchenne muscular dystrophy; Cardiomyopathy; Dystrophin deficiency | 2019-08-02 | no assertion criteria provided | clinical testing |